Article Information
History
- December 17, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mauro Gori, MD*,1,
- Carlo Berzuini, PhD*,8,13,
- Emilia D’Elia, MD PhD1,
- Arianna Ghirardi, PhD5,
- Luisa Bernardinelli, PhD9,
- Antonello Gavazzi, MD5,
- Giulio Balestrieri, MD1,
- Andrea Giammarresi, MD1,5,
- Roberto Trevisan, MD6,
- Fabiano Di Marco, MD PhD2,11,
- Antonio Bellasi, MD7,
- Mariangela Amoroso, MD2,
- Federico Raimondi, MD2,11,
- Luca Novelli, MD2,
- Bianca Magro, MD3,
- Gianpaolo Mangia, MD3,
- Ferdinando L. Lorini, MD4,
- Giulio Guagliumi, MD1,
- Stefano Fagiuoli, MD3,
- Gianfranco Parati, MD#+,10,12 and
- Michele Senni, MD#,1
- 1Cardiovascular Department, Italy
- 2Unit of Pulmonary Medicine, Italy
- 3Gastroenterology Hepatology and Transplantation Unit, Italy
- 4Intensive Care Unit, Italy
- 5FROM Research Foundation, Italy
- 6Endocrinology Unit, Italy
- 7Department of Research, Innovation, Brand Reputation, Italy
- 8ASST Papa Giovanni XXIII – Bergamo. From the Department of Biostatistics, School of Health Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
- 9Department of Brain and Behavioural Sciences, The University of Pavia, Italy
- 10From the Istituto Auxologico Italiano, IRCCS, Dept. of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital, Italy
- 11Milano; University of Milan, Italy
- 12Milan, Department of Medicine and Surgery, University of Milan-Bicocca, Italy
- 13The University of Manchester, Manchester M13 9PL, UK
- ↵+Corresponding author: Gianfranco Parati, MD, FESC, Dept. Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, IRCCS, Istituto Auxologico Italiano & University of Milano-Bicocca; P.za Brescia, 20; 20149 Milan, Italy; gianfranco.parati{at}unimib.it, Fax:+3902619112956, Mobile:+393356043581
Posted December 17, 2020.
Exposure to Renin-Angiotensin System Inhibitors Is Associated with Reduced Mortality of Older Hypertensive Covid-19 Patients
